NEW YORK, Aug. 5 NY-NeoStem-stem-cell
NEW YORK, Aug. 5 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS)
announced today that the new Southern Florida stem cell collection center
located in Coral Gables, a suburb of Miami, is targeted to open in September.
The center is being opened pursuant to an agreement with CelVida LLC. With
the opening of this center, NeoStem has secured a key geographic stronghold in
an area that is open to a large U.S. market as well as a growing sophisticated
South American presence.
Chester Amedia, Jr. MD, FACP, is the Founder and President of CelVida LLC
and has had extensive business and patient care experience in the fields of
disease management and extracorporeal therapy. "We are thrilled to be part
of what many believe to be an emerging "Stem Cell Revolution" and have chosen
to strategically align with NeoStem to provide individuals looking for a
proactive approach to their future medical care the opportunity to have their
stem cells collected and preserved for use in the future in the event of
medical need," stated Dr. Amedia. "It is estimated that by 2017 there will be
as many as 2 million annual procedures that will include stem cell based
therapies for diabetes, orthopedic injuries, cardiovascular disease,
inflammatory diseases, among others."
"We are thrilled to be working with such an accomplished physician who has
demonstrated success in building a flourishing medical business. We believe
that patient specific stem cell collection and storage one day will be viewed
as being as routine as securing health insurance. We continue to see an
abundance of evidence in the scientific literature as data from clinical
trials supports the proposition that autologous adult stem cell therapies are
emerging as an important measure in repairing degenerated, damaged and
diseased tissue (the three "Ds" of aging)," said Robin Smith, MD, CEO of
NeoStem.
About CelVida LLC
CelVida was organized to develop a network of personal self-care centers
in key metropolitan markets around the country. The CelVida network intends
to make the simple process of stem cell collection and storage available to
individuals proactively seeking healthcare options that embrace new
technologies.
About NeoStem, Inc.
NeoStem is managing a network of adult stem cell collection centers,
enabling people (through its proprietary technology) to donate and store their
own (autologous) stem cells when they are young and/or relatively healthy for
their personal use in times of future medical need. The Company has also
recently entered into research and development through the acquisition of a
worldwide exclusive license to technology to identify and isolate VSELs (very
small embryonic-like stem cells), which have been shown to have several
physical characteristics that are generally found in embryonic stem cells.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the date of this
press release, and involve certain risks and uncertainties. The Company's
actual results could differ materially from those anticipated in these
forward-looking statements as a result of various factors. Factors that could
cause future results to materially differ from the recent results or those
projected in forward-looking statements include the "Risk Factors" described
in the Company's periodic filings with the Securities and Exchange Commission.
Contact:
NeoStem, Inc.
Robin Smith, Chief Executive Officer
T: 212-584-4180
E: rsmith@neostem.com
www.neostem.com
SOURCE NeoStem, Inc.
